AMALYA BALAYAN: Open Payments
NPI 1205548245 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 22 payments from 8 companies in 2025. Trend: 2023 $246 · 2024 $75 · 2025 $679
Food & beverage: $594Education: $85
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $247 |
| Janssen Biotech, Inc. | 5 | $218 |
| ABBVIE INC. | 5 | $92 |
| RedHill Biopharma Inc. | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Boston Scientific Corporation | 1 | $27 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
Products named: REZDIFFRA, TREMFYA, LINZESS, CREON, Talicia, VOQUEZNA, SpyGlass Discover, OCALIVA.
Industry payments across CA — which companies pay providers there.
